Literature DB >> 15617998

Medical history and risk for lymphoma: results of a population-based case-control study in Germany.

Nikolaus Becker1, Evelin Deeg, Thomas Rüdiger, Alexandra Nieters.   

Abstract

Since lymphomas are malignancies of cells of the immune system, associations with disorders characterised by impaired immune functions can be assumed. We investigated the relationship between a history of selected medical conditions and the risk for lymphoma including specified subentities within our population-based case-control study of lymphoma among adults conducted in Germany between 1999 and 2002. Overall, we found decreased risks for a history of repeated diarrhoea, warts, arthrosis, allergies, and appendectomy (at a younger age). Elevated risks for lymphoma correlated with tonsillectomy (at a younger age), whereas null results were found for selected auto-immune disorders in adulthood. Although the numbers are small, most of the results for the subentities corresponded with these findings. These results are compatible with the notion that persistent immunological alterations contribute to the aetiology of lymphoma, but partially inconsistent with the Th1/Th2-shift paradigm.

Entities:  

Mesh:

Year:  2005        PMID: 15617998     DOI: 10.1016/j.ejca.2004.08.028

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Occupation and malignant lymphoma: a population based case control study in Germany.

Authors:  B Mester; A Nieters; E Deeg; G Elsner; N Becker; A Seidler
Journal:  Occup Environ Med       Date:  2006-01       Impact factor: 4.402

2.  Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.

Authors:  Nikolaus Becker; Paul Schnitzler; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadié; Alexandra Nieters; Anthony Staines; Yolanda Benavente; Pierluigi Cocco; Silvia de Sanjose
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-06       Impact factor: 4.553

3.  Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  Claire M Vajdic; Michael O Falster; Silvia de Sanjose; Otoniel Martínez-Maza; Nikolaus Becker; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; Eleanor Kane; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

4.  Medical history and risk of lymphoma: results of a European case-control study (EPILYMPH).

Authors:  Nikolaus Becker; Joan Fortuny; Tomas Alvaro; Alexandra Nieters; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Paolo Boffetta; Pier Luigi Cocco; Silvia de Sanjose
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-11       Impact factor: 4.553

5.  Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study.

Authors:  Heather A Lankes; Angela J Fought; Andrew M Evens; Dennis D Weisenburger; Brian C-H Chiu
Journal:  Cancer Causes Control       Date:  2008-11-15       Impact factor: 2.506

Review 6.  National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Authors:  Alexa B Kimball; Dafna Gladman; Joel M Gelfand; Kenneth Gordon; Elizabeth J Horn; Neil J Korman; Gretchen Korver; Gerald G Krueger; Bruce E Strober; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2008-03-04       Impact factor: 11.527

7.  Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

Authors:  Karin Ekström Smedby; Claire M Vajdic; Michael Falster; Eric A Engels; Otoniel Martínez-Maza; Jennifer Turner; Henrik Hjalgrim; Paolo Vineis; Adele Seniori Costantini; Paige M Bracci; Elizabeth A Holly; Eleanor Willett; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Nikolaus Becker; Silvia De Sanjosé; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Andrew E Grulich; Wendy Cozen
Journal:  Blood       Date:  2008-02-08       Impact factor: 22.113

8.  Asbestos exposure and malignant lymphoma: a multicenter case-control study in Germany and Italy.

Authors:  Andreas Seidler; Nikolaus Becker; Alexandra Nieters; Rolf Arhelger; Birte Mester; Karin Rossnagel; Evelin Deeg; Gine Elsner; Massimo Melis; Simonetta Sesler; Giuseppe Avataneo; Michele Meloni; Pierluigi Cocco
Journal:  Int Arch Occup Environ Health       Date:  2009-12-25       Impact factor: 3.015

Review 9.  Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.

Authors:  Sophia S Wang; Claire M Vajdic; Martha S Linet; Susan L Slager; Jenna Voutsinas; Alexandra Nieters; Silvia de Sanjose; Wendy Cozen; Graciela S Alarcón; Otoniel Martinez-Maza; Elizabeth E Brown; Paige M Bracci; Tracy Lightfoot; Jennifer Turner; Henrik Hjalgrim; John J Spinelli; Tongzhang Zheng; Lindsay M Morton; Brenda M Birmann; Christopher R Flowers; Ora Paltiel; Nikolaus Becker; Elizabeth A Holly; Eleanor Kane; Dennis Weisenburger; Marc Maynadie; Pierluigi Cocco; Lenka Foretova; Anthony Staines; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Qing Lan; Angela Brooks-Wilson; Anneclaire J De Roos; Martyn T Smith; Eve Roman; Paolo Boffetta; Anne Kricker; Yawei Zhang; Christine Skibola; Stephen J Chanock; Nathaniel Rothman; Yolanda Benavente; Patricia Hartge; Karin E Smedby
Journal:  Am J Epidemiol       Date:  2015-02-23       Impact factor: 5.363

10.  Solvent exposure and malignant lymphoma: a population-based case-control study in Germany.

Authors:  Andreas Seidler; Matthias Möhner; Jürgen Berger; Birte Mester; Evelin Deeg; Gine Elsner; Alexandra Nieters; Nikolaus Becker
Journal:  J Occup Med Toxicol       Date:  2007-04-02       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.